Plexin-B2 is a particularly strong candidate as a promoter of GBM invasion, as it was originally discovered due to its upregulation in brain cancers18, and subsequent analysis confirmed Plexin-B2 as a biomarker for malignant glioma based on patient data19. Here, PLXNB2 is linked to malignant glioma.